← Open Payments lookup

LIZETTE EBOT: Open Payments

NPI 1508448739 · WICHITA FALLS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,557 in 94 payments from 12 companies in 2025. Trend: 2023 $1,553 · 2024 $1,557 · 2025 $1,557

Food & beverage: $1,557
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.19$347
Otsuka America Pharmaceutical, Inc.20$343
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)22$299
Teva Pharmaceuticals USA, Inc.12$173
Vanda Pharmaceuticals Inc.5$91
Lundbeck LLC3$62
Alkermes, Inc.3$55
Takeda Pharmaceuticals U.S.A., Inc.3$54
E.R. Squibb & Sons, L.L.C.2$42
Axsome Therapeutics, Inc.2$37

Products named: REXULTI, INGREZZA, CAPLYTA, UZEDY, FANAPT, AUSTEDO XR, ARISTADA, TRINTELLIX.

Industry payments across TX — which companies pay providers there.